Research Article
A Novel Gene Signature to Predict Survival Time and Incident Ventricular Arrhythmias in Patients with Dilated Cardiomyopathy
Table 1
Baseline parameters in NIDCM patients with and without ventricular arrhythmia.
| | Clinical features | SR (12) | VA (6) | value |
| | Age (y) | 30.33 (16.87) | 39.33 (16.17) | 0.296 | | Male sex ( (%)) | 7 (58.3) | 3 (50.0) | 0.563 | | LA (mm) | 41.08 (13.53) | 35.33 (17.78) | 0.454 | | LVEDD (mm) | 68.00 (11.72) | 58.33 (28.74) | 0.318 | | LVEF (%) | 27.00 (11.50) | 24.00 (13.74) | 0.631 | | AF (%) | 2 (16.7) | 2 (33.3) | 0.407 | | NYHA functional class | | | | | II | 2 (16.7) | 0 (0.0) | 0.806 | | III | 4 (33.3) | 2 (33.3) | | | IV | 6 (50.0) | 4 (66.7) | | | Diabetes mellitus (%) | 1 (8.3) | 1 (16.7) | 0.569 | | Smoking history (%) | 2 (16.7) | 1 (16.7) | 0.755 | | Drug therapy | | | | | Amiodarone (%) | 1 (8.3) | 2 (33.3) | 0.245 | | β-Blockers (%) | 8 (66.7) | 4 (66.7) | 0.691 | | Digoxin (%) | 10 (83.3) | 4 (66.7) | 0.407 | | ACEI/ARB (%) | 10 (83.3) | 4 (66.7) | 0.407 | | CCB (%) | 2 (16.7) | 1 (16.7) | 0.755 | | Diuretic (%) | 11 (91.7) | 5 (83.3) | 0.569 |
|
|
Values are , (%); LA: left atrium; LVEDD: left ventricular diastolic diameter; LVEF: left ventricular ejection fraction; AF: Atrial fibrillation; NYHA: New York Heart Association; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. |
